{"id":"W2138647255","doi":"10.1016/s0140-6736(14)62113-9","title":"Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":394,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Etanercept; Tofacitinib; Placebo; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Plaque psoriasis; Janus kinase inhibitor; Population; Randomized controlled trial; Surgery; Dermatology; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000883191,0.0003073142,0.0008820242,0.00008798633,0.0001474883,0.00003907217,0.0004546049,0.0002869068,0.0006318605],"category_scores_gemma":[0.0003015525,0.0001933983,0.0001281493,0.0002371365,0.00008793283,0.00009696746,0.00008575715,0.0003052508,0.0009438564],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002063502,"about_ca_system_score_gemma":0.0004143248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001600439,"about_ca_topic_score_gemma":0.0007287245,"domain_scores_codex":[0.9979686,0.000596897,0.000378958,0.0003762316,0.0000720273,0.0006073611],"domain_scores_gemma":[0.9986817,0.0004815136,0.0001108366,0.0006064395,0.00004875757,0.00007077777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9699939,0.0002882947,0.00006524039,0.0000120269,0.0003312616,0.00003887027,0.001786543,0.0001356956,0.002866484,0.00005149778,0.01228023,0.01214994],"study_design_scores_gemma":[0.9570472,0.001898997,0.0001110985,0.00004128885,0.0001876127,0.00002900682,0.0003711279,0.00007221795,0.007665079,0.00007625255,0.03216549,0.0003345984],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903549,0.000606904,0.00007621714,0.000866037,0.002788353,0.001924178,0.0002814583,0.0001031895,0.002998774],"genre_scores_gemma":[0.9959075,0.0001426012,0.00007786611,0.0002055925,0.001004099,0.0005685528,0.0001978429,0.0000258432,0.001870056],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01988525,"threshold_uncertainty_score":0.999834,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07837364539587272,"score_gpt":0.324495817594725,"score_spread":0.2461221721988522,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}